arrow_back Back to App

Support for National Security Threat Drugs Extended Until 2033.

This act extends a program that encourages the development of drugs for national security threats. This means pharmaceutical companies will have longer incentives to create new treatments, potentially increasing the availability of medicines in case of serious health threats to citizens.
Key points
The priority review program for drugs addressing national security threats has been extended by 10 years, until 2033.
This aims to accelerate research and development of new medicines that can protect public health in crisis situations.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5708
Sponsor: Rep. Finstad, Brad [R-MN-1]
Process start date: 2023-09-26